Randomised controlled trials and other prospective clinical studies for novel medical
interventions in people with diabetes have traditionally reported HbA 1c as the measure of …

Abstract Purpose of Review The incidence of type 1 diabetes (T1D) is rising in all age
groups. T1D is associated with chronic microvascular and macrovascular complications but …

Aim To evaluate continuous glucose monitoring (CGM) metrics for use as alternatives to
glycated haemoglobin (HbA1c) to evaluate therapeutic efficacy. Methods We re‐analysed …

Objective: The safety and impact of the advanced hybrid closed-loop (AHCL) system on
glycemic outcome in 2-to 6-year-old children with type 1 diabetes and the diabetes distress …

Background: The aim of this multicenter observational real-world study was to investigate
glycemic outcomes in children and adolescents with type 1 diabetes over the first 6-month …

Background: With the proliferation of continuous glucose monitoring (CGM), a number of
metrics were developed to assess quality of glycemic control. Many of them are highly …

OBJECTIVE This study aimed to investigate the association between continuous glucose
monitoring (CGM)-derived glycemic metrics and different insulin treatment modalities using …

Aim To investigate the association between a new composite metric, glycaemia risk index
(GRI), and incident diabetic retinopathy (DR). Methods A total of 1204 adults with type 2 …

Background: The glycemia risk index (GRI) is a new composite metric derived from
continuous glucose monitoring (CGM) data to assess the quality of glycemia. This study …

Background: Automated insulin delivery is an efficient treatment for patients with type 1
diabetes. Little is known on its impact on patients with excessive time in hypoglycaemia …